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 Introduction                                                                                        
Megaloblastic anemias are a group of disorders characterized by 
peripheral blood cytopenia(s) resulting due to ineffective hematopoiesis 
in the marrow. They are usually caused by nutritional deficiencies 
(most common) of either vitamin B12 or folate; or both, inherited 
disorders of DNA synthesis, or following certain drug therapy.1 Pyrexia 
in megaloblastic anemia, albeit well known, is rarely characterized. 
However, megaloblastic anemia, solely as the cause of pyrexia, can be 
found in only a small proportion of cases, for which differentiation from 
fever of unknown origin (FUO) may be difficult even after exhaustive 
laboratory investigations.2-8
The aim of the present article was to highlight this aspect of 
megaloblastic anemia with a brief review of the existing literature 
and create awareness among practicing physicians about a 
treatable condition.
 Case Presentation                                                                                       
A 51 year old lady, vegetarian, presented to the General Medicine 
Outpatient Department of Pondicherry Institute of Medical Sciences, 
Puducherry, India, with complaints of fever, nausea with vomiting, 
and burning micturition of 3 days’ duration. The fever was on and 
off, moderate grade, and not associated with chills and rigors. She 
had easy fatigability with loss of weight and appetite. The patient 
had a history of jaundice 3 months previously, for which she had 
taken ayurvedic medications and her symptoms had resolved within a 
month. The patient had attained menopause 3 months earlier, before 
Case Report
Department of Pathology, Pondicherry 
Institute of Medical Sciences, 
Ganapathychettykulam, Puducherry, 
India
Correspondence: 
Kevin Manuel, MBBS;
Department of Pathology, 
Pondicherry Institute of Medical 
Sciences, 
PIN Code: 605014, 
Ganapathychettykulam, 
Puducherry, India
Tel: +91 413 2656271
Fax: +91 413 2656273 
Email: drkevinmanuel@gmail.com
Received: 7 July 2012
Revised: 22 August 2012
Accepted: 30 September 2012
 Abstract                                                                                                            
Deficiency of vitamin B12 and/or folic acid as a cause of pyrexia, 
though known, is rarely reported in literature. We aimed to report 
a case in a 51 year old woman, who presented with fever and 
pancytopenia and was diagnosed to have megaloblastic anemia 
secondary to vitamin B12 and folate deficiency. The pyrexia 
subsided  following  the  intramuscular  injection  of  vitamin 
B12 and oral folic acid administration. All the other infective, 
inflammatory/autoimmune, endocrine causes of pyrexia were 
excluded by appropriate investigations. Therefore, we suggest 
that all physicians be aware of megaloblastic anemia as a 
treatable cause of pyrexia in order to avoid unnecessary costly 
investigations and antibiotic usage.
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which she had regular cycles. There was no history 
of cough with expectoration, headache, arthralgia, 
and rash, and nor was there a history of recent travel 
to malaria endemic zone or exposure to any patient 
of tuberculosis.
Examination of the patient revealed pulse 
rate of 118 per minute, blood pressure of 110/70 
mm Hg (supine), and oral temperature of 38.3°C 
(101°F). She had moderate conjunctival pallor and 
scleral icterus. There was no lymphadenopathy, 
clubbing, eschar, or skin rashes. Oxygen 
saturation was 99% on room air, and there were 
no signs of respiratory distress in the patient. 
Cardiovascular examination revealed a systolic 
flow murmur in the aortic area. The respiratory 
and nervous system examinations were within 
normal limits. Her chest X-ray and abdomen 
ultrasound revealed no significant abnormalities 
except for mild hepatomegaly.
Routine hematological evaluation, on admission, 
revealed very low hemoglobin (Hb); 22 g/L (120-
160), hematocrit; 7.2% (35-45), total leukocyte count 
(TLC); 3×109/L (4-11), total platelet count (TPC); 
64.5×109/L (150-450), absolute neutrophil count; 
1.9×109/L (1.5-8×109/L), corrected reticulocyte 
count; 1.5% (0.5-2), red cell distribution width; 17.5% 
(11.5-14.5), mean corpuscular volume (MCV); 
114.3 fL (80-98), mean corpuscular hemoglobin 
(MCH); 34.9 pg (26-32), and mean corpuscular 
hemoglobin concentration (MCHC); 30.6% (32-
36). Peripheral smear showed pancytopenia 
with a moderate degree of anisopoikilocytosis 
and a good number of macrocytes, macro-
ovalocytes, and hypersegmented neutrophils. 
Bone marrow aspiration and trephine biopsy 
from the right posterior superior iliac spine 
revealed marked hypercellularity for age (70%), 
florid  erythroid  hyperplasia  with  an  altered 
myeloid to erythroid ratio (1:2), megaloblastic 
dyspoiesis, and numerous giant metamyelocytes. 
Micromegakaryocytes and/or megakaryocyte 
clustering were not seen. Perl stain showed 
adequate marrow iron stores without any ring 
sideroblasts. There was no evidence of blast 
prominence (4%), granulomas, hemoparasites, 
malignancy, or increased reticulin condensation 
(figures 1 and 2). The bone marrow morphology 
was suggestive of megaloblastic anemia, which 
was confirmed biochemically by low levels of 
serum vitamin B12 (59.6 pg/mL, reference; 180- 
900), low normal folic acid (3.9 ng/mL, reference; 
4-24), and markedly elevated serum lactate 
dehydrogenase (LDH) [10,550 IU/L, reference; 
225-420]. The patient’s routine liver and renal 
function tests were within normal limits except 
for mild unconjugated hyperbilirubinemia (total 
bilirubin; 4.8 mg/dL [0.2-1.2]/direct; 0.4 mg/dL 
[up to 0.3]). Her upper and lower gastrointestinal 
endoscopy did not show any abnormality.
Her routine microbiological (aerobic and 
anaerobic culture), serological, autoimmune, 
inflammatory (serum C-reactive protein; 3mg/L, 
ref.<10mg/L), and endocrine work-up were 
negative.  Normal viral titers along with the 
absence of reactive lymphocytes in the peripheral 
smear ruled out the possible viral etiology.
 Clinical Progression                                                                                       
Pending laboratory investigation reports, and 
in view of neutropenia, the patient was started 
prophylactically on broad spectrum intravenous 
antibiotics (on day 2) based on the protocol of 
infection management for a period of 4 days but 
the patient continued to be pyrexial. Therefore, in 
view of the positive laboratory investigations pointing 
towards megaloblastic anemia along with the 
absence of any positive microbiological findings, the 
patient was started on injection vitamin B12 and oral 
folic acid (on day 5) along with on-going parenteral 
antibiotics. Pyrexia settled on day 6 of admission with 
just vitamin B12 and folic acid therapy and, consequently, 
the antibiotics were withdrawn (figure 3).
Given the patient’s low hemoglobin, she was 
transfused with 3 units of packed cell volume. 
The patient improved symptomatically after being 
prescribed vitamin B12 and folic acid supplements, 
Figure 1: Bone marrow aspirate smear shows markedly 
increased cellularity with erythroid hyperplasia and 
trilineage dyspoiesis (Wright-Giemsa, ×400).                                
Figure 2: Bone marrow aspirate smear demonstrates 
numerous megaloblasts and giant metamyelocytes (Wright-
Giemsa, ×1000).                                                                             200 
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following which the patient was discharged in 
a stable condition. Routine follow-up (at one 
month) showed normalization of vitamin B12 
(656 pg/mL) and folate (>5 ng/mL) levels as well 
as improvement in hematological parameters 
(hemoglobin; 80 g/L, MCV; 86fL) without any 
febrile episodes.
 Discussion                                                                                       
Our patient’s dramatic response to nutritional 
supplements in our case supports the notion that 
the pyrexia was attributable directly to megaloblastic 
anemia secondary to vitamin B12 and folate deficiency 
rather than anything else, as was ruled out by 
appropriate available diagnostic modalities. As per 
the modified Petersdorf criteria,2 FUO is defined as: 
1) a temperature exceeding 38.3°C; 2) duration of the 
fever of more than three weeks; and 3) evaluation of 
three outpatient visits or three days in hospital. Our 
patient satisfied two out of the three criteria (1 and 3).
In a study by Tahlan et al.3 the incidence 
of low-grade fever in nutritional megaloblastic 
anemia varied from 28% to 60% (259 of 509 
patients). Another study from Northern India 
described persistent low-grade fever in 70% of 
the females with B12 and/or folate deficiency.4 
McKee,5 reviewed 122 patients of nutritional 
megaloblastic anemia for the presence of pyrexia 
(temperature≥37.8°C [100°F]). In 49/122 (40%), 
pyrexia was attributable solely to the megaloblastic 
disease. In addition, the majority of the patients 
had a minimal rise of temperature (≤38.5°C). Only 
occasionally the values were above 38.5°C (102°F), 
and rarely were they greater than 40°C (4/49, 8%). 
Those with severe disease characterized by high 
MCV, low hematocrit (<20%), low thrombocytopenia 
(<100×109  /L), high LDH (>1000 IU/L), and 
unconjugated hyperbilirubinemia (>1.5 mg/dL) were 
more likely to be febrile. In the majority of the patients, 
fever subsided 24 to 72 hours after supplementation 
of vitamin B12 and/or folate, suggesting the rapid 
correction of ineffective hematopoiesis.
A comparative review of literature highlighting 
pyrexia in megaloblastic anemia is presented 
in table 1. Carpenter et al.6 described a 38 
year old female patient who presented with 
chronic, low-grade intermittent fever (37.8°C), 
Figure 3: Line Chart shows the patient’s temperature 
during the course of illness in the hospital.                              
Table 1: Comparison of the present case of pyrexia and megaloblastic anemia with similar cases published in the literature
Author, year, 
(no. of cases)
Age, 
sex
Fever Hemogram Pathology Response 
to vitamin 
supplement 
Duration Temp. Peripheral 
blood smear
MCV 
(80-
98fL)
Serum B12 
(190-900 
pg/mL)
Serum 
folate 
(5-24 ng/
mL)
Carpenter et al.6 
2000, (1)
38, 
Female
6 ½ weeks, 
persistent, 
low grade, 
dominant 
presentation
37.8°C Macrocytosis 
(Hct; 42.7%, 
TLC; 9.1×109/L, 
TPC; 2.7×109/L)
104 115 Normal Pernicious 
anemia, gastric 
adenocarcinoma (GE# 
junction), bone marrow 
not done
Not 
assessed,
death 4 
months post 
gastrectomy
Negi et al.7 
2011, (1)
18, 
Male
3 days  103.6°F 
(39.7°C)
Bicytopenia (Hb; 
38g/L, TLC; 
3.2×109/L, TPC; 
WNL)
105 105 5.05 Dimorphic bone 
marrow picture, mild 
splenomegaly, no 
icterus 
Afebrile after 
72 hours
Singanayagam 
et al.8 2008, (1)
29, 
Male
6 weeks 38.8°C Pancytopenia 
(Hb; 28g/L, 
TLC; 2.6×109/L, 
TPC; 26 ×109/L) 
112 202 (low 
normal)
1.2  Megaloblastic anemia 
(bone marrow), 
splenomegaly, 
mild unconjugated 
hyperbilirubinemia
Afebrile after 
48 hours (B12 
and Folate)
Present case, 
2012, (1)
51, 
Female
1 week  38°C Pancytopenia 
(Hb;22g/L,TLC; 
3×109/L, TPC; 
64.5×109/L)
114.3 59.6 3.9  Megaloblastic anemia 
(bone marrow), 
mild hepatomegaly, 
unconjugated 
hyperbilirubinemia, 
high lactate 
dehydrogenase 
Afebrile after 
24 hours (B12 
and Folate)
MCV: mean corpuscular volume; Hct: hematocrit; TLC: total leukocyte count; TPC: total platelet count; #: gastro-esophageal 
junction; Hb: hemoglobin; WNL: within normal limit201 
Pyrexia in megaloblastic anemia
Iran J Med Sci Supplement June 2013; Vol 38 No 2
mild macrocytosis (MCV=104 fL), and normal 
hematocrit secondary to chronic atrophic 
gastritis, low vitamin B12 (115 pg/mL, reference 
range: 190-900 pg/mL), and co-existent proximal 
intestinal type gastric adenocarcinoma. The 
pathophysiological mechanism for her pyrexia 
could have been attributed to either nutritional 
deficiency secondary to chronic atrophic gastritis 
of pernicious anemia or release of tumoral 
cytokines (Interleukin-6); or both. However, 
response to vitamin B12 supplementation therapy 
was not documented in that case, and the patient 
expired due to metastatic disease following 
gastrectomy. Negi et al.7 reported a case of 
anicteric male with pyrexia (39.7°C), bicytopenia, 
and macrocytosis (MCV=105 fL) secondary to 
B12 deficiency (105 pg/mL). Singanayagam et 
al.8 reported a young male with pyrexia of 6 
weeks’ duration (38.8°C), severe pancytopenia, 
and mild hyperbilirubinemia secondary to folate 
deficiency (1.2 ng/mL, reference range: 5-24 
ng/mL) and low normal vitamin B12 (202 pg/
mL). The present report described a case of 
megaloblastic anemia in a middle-aged female 
patient, who presented with low-grade pyrexia, 
pancytopenia, macrocytosis (114.3 fL), very 
high LDH (10,550 IU/L, reference range: 225-420 
IU/L), and mild unconjugated hyperbilirubinemia; 
secondary to combined deficiency of B12 (59.6 pg/
mL) and folate (3.9 ng/mL). In all the three cases 
(including the present one) as was described above, 
pyrexia subsided 24 to 72 hours after initiation of 
supplementation therapy.
The exact cause of fever in megaloblastic 
anemia is unknown and at present, seems more 
hypothetical rather than conclusive. Association 
of pyrexia and megaloblastic anemia appears to 
be causal, whereas in other types of anemias, it 
seems more coincidental. Megaloblastic anemia 
is a panmyelosis, characterized by hypercellular 
marrow and ineffective hematopoiesis. Premature 
destruction of hematopoietic precursors possibly 
releases intracellular substances, which might 
function as systemic pyrogens. As was suggested 
by the researchers, dramatic response to B12 and/
or folate supplementation (within 24 to 72 hours) 
strongly supports the above-said hypothesis. 
Alternatively, the defective oxygenation at the 
thermoregulatory center of the hypothalamus might 
be the explanation for pyrexia. However, lack of 
correlation between neurological manifestation and 
pyrexia in megaloblastic disease does not support 
this theory.5 Moreover, studies have also shown 
that a rise in temperature might cause depletion 
of folate stores, both in red blood cells and serum, 
leading to disturbance of folate metabolism. So 
whether pyrexia is the cause of folate deficiency or 
vice versa is yet to be fully understood.9
 Conclusion                                                                                       
All patients presenting with pyrexia and cytopenia 
should be carefully evaluated for possible vitamin 
B12 and folate deficiency in order to prevent the 
unnecessary use of antibiotics. Larger studies 
highlighting the possible role of cytokine signaling 
and bone marrow stromal microenvironment 
might throw some light in understanding the 
pathophysiological mechanism of pyrexia in 
megaloblastic anemia.
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